Marc Schiltz reveals the ambitions of Luxembourg’s National Research Fund (FNR), how his team are encouraging integration and doing far more than…

Walter Steinlin describes the Federal Commission of Technology and Innovation as a catalyst for turning research into innovation. Based in Bern,…

Prof. Dr. István Vályi-Nagy, Director General of the United St. Istvan and St. Laszlo Hospitals, shares his insights on running one of the largest…

Laurent Levy, CEO at Nanobiotix, is leading the way in nanomedicine with new market-disruptive developments, establishing a growing presence in…

Prof. Luigi Naldini, Director of TIGET, discusses the success of the institute and the groundbreaking partnerships it has formed with the…

The CEO and CFO of SkylineDx talk about the company’s latest product, the MMprofiler™, a prognostic test to determine the level of risk of a…

Thomas Würdinger, winner of the 2014 Galenus prize, discusses his research team’s efforts to developing new treatment options and protocols for…

The owner of Altis Biologics, Nick Duneas, illustrates the significance of the company’s flagship product, the Altis Osteogenic Bone Matrix (OBM)…

The Netherlands Cancer Institute (NKI) has been at the international forefront of cancer research and treatment for more than 100 years. The director…

The Center for Pharmaceutical Engineering and Learning (CPEDaL) was established in 2006 as a ten year training program that is currently awaiting…